Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Thumb stiffness-brachydactyly-intellectual disability syndrome is characterized by intellectual deficit, mild dysmorphism, type A brachydactylia, signs of obesity and ankylosis of both thumbs. It has been reported in several females from one family (a girl and her mother, her grandmother and probably also her sister and her great-aunt), as well as in an isolated case.
Features include: Type A1 brachydactyly, Global developmental delay, and Intellectual disability.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Global developmental delay, Intellectual disability |
Biomarker and diagnostic research for thumb stiffness-brachydactyly-intellectual disability syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for thumb stiffness-brachydactyly-intellectual disability syndrome.
156 publications have been identified in PubMed for thumb stiffness-brachydactyly-intellectual disability syndrome. Research spans Review / Meta-Analysis (58%), Case Report / Case Series (13%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 90 | 58% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 1:02 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies |
20 |
13% |
Laboratory research | 20 | 13% |
Disease patterns and progression | 11 | 7% |
Clinical study results | 8 | 5% |
Testing and diagnosis research | 3 | 2% |
Other research | 2 | 1% |
New treatment approaches | 2 | 1% |
Ninkovic M (2026). [PMID: 41271491](https://pubmed.ncbi.nlm.nih.gov/41271491/). *J Plast Reconstr Aesthet Surg*. [Clinical Trial Publication]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Cenciarelli S (2026). [PMID: 42071175](https://pubmed.ncbi.nlm.nih.gov/42071175/). *Am J Med Genet A*. [Case Report / Case Series]
Buel KL (2026). [PMID: 41569909](https://pubmed.ncbi.nlm.nih.gov/41569909/). *FP Essent*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]
Xu J (2026). [PMID: 41790631](https://pubmed.ncbi.nlm.nih.gov/41790631/). *Medicine (Baltimore)*. [Case Report / Case Series]
Yilmaz SO (2026). [PMID: 41937270](https://pubmed.ncbi.nlm.nih.gov/41937270/). *Am J Med Genet A*. [Case Report / Case Series]
Inami K (2026). [PMID: 41741973](https://pubmed.ncbi.nlm.nih.gov/41741973/). *Hand (N Y)*. [Clinical Trial Publication]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]